Rheumatic fever

Paediatric Cardiology

Volumn , Issue , 2010, Pages 1091-1113

  Coelho Mota, Cleonice C ^a,b   Aiello, Vera Demarchi ^c   Anderson, Robert H ^d  

^a Faculty of Medicine ABC (FMABC)   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857038425     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-3064-2.00057-6     Document Type: Chapter

References (206)

1. World Health Organization Rheumatic Fever and Rheumatic Heart Disease: Report of a WHO Expert Consultation. Geneva, 29 October-1 November 2001. WHO technical report series No. 923 2004, WHO, Geneva.
2. Markowitz M. The changing picture of rheumatic fever. Arthritis Rheum 1977, 20:369-374.
3. Kaplan E.L., Markowitz M. The fall and rise of rheumatic fever in the United States: A commentary. Int J Cardiol 1988, 21:3-10.
4. Acierno L.J. The History of Cardiology. 1994, Parthenon Publishing, London, p 758.
5. Homer C., Shulman S.T. Clinical aspects of acute rheumatic fever. J Rheumatol 1991, 18:2-13.
6. Taranta A., Markowitz M. Rheumatic Fever 1989, Kluwer Academic, Boston, p 99. 2nd ed.
7. Clendening L. Source Book of Medical History. 1942, Dover,, New York, p 685.
8. Veasy L.G. Rheumatic fever-T. Duckett Jones and the rest of the story. Cardiol Young 1995, 5:293-301.
9. Glover J.A. Incidence of rheumatic heart disease. Lancet 1930, 1:500-505.
10. Glover J.A., Griffith F. Acute tonsillitis and some of its sequels: Epidemiological and bacteriological observations. BMJ 1931, 2:521-527.
11. Collins W.R.F. Acute rheumatism and haemolytic streptococci. Lancet 1931, 1:1341-1345.
12. Todd E.W. Antihaemolysin titres in haemolytic streptococcal infections and their significance in rheumatic fever. Br J Exp Pathol 1932, 13:248-259.
13. Lancefield R.C. A serological differentiation of human and other groups of hemolytic streptococci. J Exp Med 1933, 57:571-595.
14. Coburn A.F., Moore L.V. The prophylactic use of sulfanilamide in streptococcal respiratory infections, with special reference to rheumatic fever. J Clin Invest 1939, 18:147-155.
15. Denny F.W., Wannamaker L.W., Brink W.R. Prevention of rheumatic fever: Treatment of the preceding streptococcic infection. JAMA 1950, 143:151-153.
16. Wannamaker L.W. Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. Am J Med 1951, 10:673-685.
17. Jones T.D. The diagnosis of rheumatic fever. JAMA 1944, 126:481-484.
18. Rutstein D.D., Bauer W., Dorfman A., et al. Jones Criteria (Modified) for Guidance in the Diagnosis of Rheumatic Fever: Report of the Committee on Standards and Criteria for Programs of Care. Circulation 1956, 13:617-620.
19. Stollerman G.H., Markowitz M., Taranta A., et al. Jones Criteria (Revised) for Guidance in the Diagnosis of Rheumatic Fever: Report of the ad hoc Committee on Rheumatic Fever and Congenital Heart Disease of American Heart Association. Circulation 1965, 32:664-668.
20. Shulman S.T., Kaplan E.L., Bisno A.L., et al. Jones Criteria (Revised) for Guidance in the Diagnosis of Rheumatic Fever. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the American Heart Association. Circulation 1984, 70:204A-208A.
21. Guidelines for the diagnosis of rheumatic fever Jones criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 1992, 268:2069-2073.
22. Ferrieri P., Baddour L., Bolger A., et al. Proceedings of Jones Criteria Workshop (AHA Scientific Statement). Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. Circulation 2002, 106:2521-2523.
23. Tani L.Y., Veasy L.G., Minich L.L.A., Shaddy R.E. Rheumatic fever in children younger than 5 years: Is the presentation different?. Pediatrics 2007, 112:1065-1068.
24. Canter B., Olguntürk R., Tunaoglu F.S. Rheumatic fever in children under 5 years old. Pediatrics 2007, 114:329-330.
25. Chockalingam A., Gnanavelu G., Elangovan S., Chockalingam V. Clinical spectrum of chronic rheumatic heart disease in India. J Heart Valve Dis 2003, 12:577-581.
26. Mota C.C.C., Meira Z.M.A. Rheumatic fever. Cardiol Young 1999, 9:239-248.
27. Deshpande J., Vaideeswar P., Amonkar G., Vasandani S. Rheumatic heart disease in the past decade: An autopsy analysis. Indian Heart J 2002, 54:676-680.
28. Kaplan E.L., Markowitz M. Assessing the risk of adverse reactions to intramuscular benzathine penicillin G. Am J Manag Care 1999, 5:923-926.
29. Bisno A.L., Gerber M.A., Gwaltney J.M., et al. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis 2002, 35:113-125.
30. Stollerman G.H. Current issues in the prevention of rheumatic fever. Minerva Med 2002, 93:371-387.
31. Carapetis J.R., Currie B.J., Good M.F. Towards understanding the pathogenesis of rheumatic fever. Scand J Rheumatol 1996, 25:127-131.
32. Martin J.M., Green M. Group A streptococcus. Semin Pediatr Infect Dis 2006, 17:140-148.
33. Steer A., Carapetis J., Molan T.M., Shann F. Systematic review of rheumatic heart disease prevalence in children in developing countries: The role of environmental factors. J Paediatr Child Health 2002, 38:229-234.
34. Carapetis J.R., Currie B.J., Mathews J.D. Cumulative incidence of rheumatic fever in an endemic region: A guide to the susceptibility of the population?. Epidemiol Infect 2000, 124:239-244.
35. Chun L.T., Reddy V.D., Yamamoto L.G. Rheumatic f ever in children and adolescents in. Hawaii. Pediatrics 1987, 79:549-552.
36. Thornley C., McNicolas A., Baker M., Lennon D. Rheumatic fever registers in New Zealand. Public Health Rep 2001, 8:45-48.
37. Maharaj B., Dyer R.B., Leary W.P., et al. Screening for rheumatic heart disease amongst black schoolchildren in Inanda, South Africa. J Trop Pediatr 1987, 33:60-61.
38. Rimoin A.W., Hamza H.S., Vince A., et al. Evaluation of the WHO clinical decision rule for streptococcal pharyngitis. Arch Dis Child 2005, 90:1066-1070.
39. Dajani A.S. Rheumatic fever. Heart Disease 2001, 2192. WB Saunders, Philadelphia, rev. 6th ed. E. Braunwald, D.P. Zipes, P. Libby (Eds.).
40. Kaplan E.L. Global assessment of rheumatic fever and rheumatic heart disease at the close of the century-Influences and dynamics of populations and pathogens: A failure to realize prevention?. Circulation 1993, 88:1964-1972.
41. Cunningham M.W. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000, 13:470-511.
42. Veasy L.G., Tani L.Y., Daly J.A., et al. Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 2004, 113:168-172.
43. Shulman S.T., Stollerman G., Beall B., et al. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States. Clin Infect Dis 2006, 42:441-447.
44. Markowitz M., Kuttner A.G., Gordis L. Rheumatic Fever: Diagnosis, Management and Prevention 1965, WB Saunders, Philadelphia, p 242.
45. Meira Z.M.A., Goulart E.M., Colosimo E.A., Mota C.C.C. Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents. Heart 2005, 91:1019-1022.
46. Carapetis J.R., Steer A.C., Mulholland E.K., Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005, 5:685-694.
47. Gordis L. The virtual disappearance of rheumatic fever in the United States: Lessons in the rise and fall of disease. Circulation 1985, 72:1155-1162.
48. World Health Organization The WHO Programme on Streptococcal Disease Complex: Report of a Consultation. Geneva 1998, WHO, Geneva, 16-19 February 1998. WHO document No. EMC/BAC/98.7.
49. Soler-Soler J., Galve E. Valve disease: Worldwide prospective of valve disease. Heart 2000, 83:721-725.
50. Mortimer E.A. Control of rheumatic fever: How are we doing?. JAMA 1997, 237:1720.
51. Bisno A.L., Shulman S.T., Dajani A.S. The rise and fall (and rise?) of rheumatic fever. JAMA 1988, 259:728-729.
52. Markowitz M. Rheumatic fever-a half-century perspective. Pediatrics 1998, 102(Suppl):272-274.
53. Massel B.F., Chute C.G., Walker A.M., Kurland G.S. Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. N Engl J Med 1988, 318:280-286.
54. Miyake C.Y., Gauvreau K., Tani L.Y., et al. Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever. Pediatrics 2007, 120:503-508.
55. De Santis M., Fesslova V., Salice S., et al. A possible comeback of rheumatic fever in Northern Italy. Riv Ital Pediatr 2003, 29:217-221.
56. Giannoulia-Karantana A., Anagnostopoulos G., Georgakopoulou T., et al. Childhood acute rheumatic fever in Greece: Experience of past 18 years. Acta Paediatr 2001, 90:809-812.
57. Williamson L., Bowness P., Mowat A., Östman-Smith E. Difficulties in diagnosing acute rheumatic fever: Arthritis may be short lived and carditis silent. BMJ 2000, 320:362-365.
58. Guilherme L., Fae K., Oshiro S.E., Kalil J. Molecular pathogenesis of rheumatic fever and rheumatic heart disease. Expert Rev Mol Med 2005, 7:1-15.
59. Sakota V., Fry A.M., Lietman T.M., et al. Genetically diverse group A streptococci from children in far-western Nepal share high genetic relatedness with isolates from other countries. J Clin Microbiol 2006, 44:2160-2166.
60. Teixeira L.M., Barros R.R., Castro A.C., et al. Genetic and phenotypic features of S treptococcus pyogenes strains isolated in Brazil that harbor new emm sequences. J Clin Microbiol 2001, 39:3290-3295.
61. Martin J.M., Barbadora K.A. Continued high caseload of rheumatic fever in western Pennsylvania: Possible rheumatogenic emm types of Streptococcus pyogenes. J Pediatr 2006, 149:58-63.
62. Pruksakorn S., Sittisombut N., Phornphutkul C., et al. Epidemiological analysis of non-M-typeable group A Streptococcus isolates from a Thai population in northern Thailand. J Clin Microbiol 2000, 38:1250-1254.
63. Hernandez-Pacheco G., Flores-Dominguez C., Rodriguez-Perez J.M., et al. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease. J Autoimmun 2003, 21:59-63.
64. Ramasawmy R., Fae K.C., Spina G., et al. Association of polymorphisms within the promoter region of the tumor necrosis factor-alpha with clinical outcomes of rheumatic fever. Mol Immunol 2007, 44:1873-1878.
65. Galvin J.E., Hemric M.E., Ward K., Cunningham M.W. Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Invest 2000, 106:217-224.
66. Goldstein I., Halpern B., Robert L. Immunological relationship between streptococcus A polysaccharide and the structural glycoproteins of heart valve. Nature 1967, 213:44-47.
67. Roberts S., Kosanke S., Terrence Dunn S., et al. Pathogenic mechanisms in rheumatic carditis: Focus on valvular endothelium. J Infect Dis 2001, 183:507-511.
68. Kirvan C.A., Swedo S.E., Heuser J.S., Cunningham M.W. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 2003, 9:914-920.
69. Guilherme L., Cunha-Neto E., Coelho V., et al. Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation 1995, 92:415-420.
70. Guilherme L., Cury P., Demarchi L.M., et al. Rheumatic heart disease: Proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am J Pathol 2004, 165:1583-1591.
71. Mansur A.J., Grinberg M., Lopes E.A., et al. [Acute rheumatic involvement of the 4 cardiac valves in a patient with tetralogy of Fallot]. Arq Bras Cardiol 1980, 35:499-502.
72. Kamblock J., Payot L., Lung B., et al. Does rheumatic myocarditis really exist? Systematic study with echocardiography and cardiac troponin I blood levels. Eur Heart J 2003, 24:855-862.
73. Williams R.V., Minich L.L., Shaddy R.E., et al. Evidence for lack of myocardial injury in children with acute rheumatic carditis. Cardiol Young 2002, 12:519-523.
74. Narula J., Chopra P., Talwar K.K., et al. Does endomyocardial biopsy aid in the diagnosis of active rheumatic carditis?. Circulation 1993, 88:2198-2205.
75. Bisno A.L. Acute rheumatic fever: A present-day perspective. Medicine 1993, 72:278-283.
76. Juneja R., Tandon R. Rheumatic carditis: A reappraisal. Indian Heart J 2004, 56:252-255.
77. Stollerman G.H., Lewis A.J., Shultz I., Taranta A. Relationship of immune response to group A streptococci to the course of acute, chronic and recurrent rheumatic fever. Am J Med 1956, 20:163-169.
78. Chagani H.S., Aziz K. Clinical profile of acute rheumatic fever in Pakistan. Cardiol Young 2003, 13:28-35.
79. Veasy L.G., Tani L.Y. A new look at acute rheumatic mitral regurgitation. Cardiol Young 2005, 15:568-577.
80. Gupta M., Lent R.W., Kaplan E.L., Zabriskie J.B. Serum cardiac treponin I in acute rheumatic fever. Am J Cardiol 2002, 89:779-782.
81. Alehan D., Ayabakan C., Hallioglu O. Role of serum cardiac troponin T in the diagnosis of acute rheumatic fever and rheumatic carditis. Heart 2004, 90:689-690.
82. Gentles T.L., Colan S.D., Wilson N.J., et al. Left ventricular mechanics during and after acute rheumatic fever: Contractile dysfunction is closely related to valve regurgitation. J Am Coll Cardiol 2001, 37:201-207.
83. Barlow J.B., Marcus R.H., Pocock W.A., et al. Mechanisms and management of heart failure in active rheumatic carditis. S Afr Med J 1990, 78:181-186.
84. Essop M.R., Wisenbaugh T., Sareli P. Evidence against a myocardial factor as a cause of left ventricular dilatation in active rheumatic carditis. J Am Coll Cardiol 1993, 22:826-829.
85. Vasan R.S., Shrivastava S., Vijayakumar M., et al. Echocardiographic evaluation of patients with acute rheumatic fever and rheumatic carditis. Circulation 1996, 94:73-82.
86. Steinfield L., Ritter S., Pappaport H., Martinez E. Silent mitral regurgitation unmasked by Doppler studies. Circulation 1986, (Suppl II):385.
87. Veasy L.G., Wiedmeier S.E., Orsmond G.S., et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 1987, 316:421-427.
88. Folger G.M., Hajar R. Doppler echocardiographic findings of mitral and aortic valvular regurgitation in children manifesting only rheumatic arthritis. Am J Cardiol 1989, 63:1278-1280.
89. Mota C.C.C. Limitations and perspectives with the approach to rheumatic fever and rheumatic heart disease. Cardiol Young 2005, 15:580-582.
90. Lanna C.C.D., Tonelli E., Mota C.C.C., et al. Subclinical rheumatic valvitis: A long-term follow-up. Cardiol Young 2003, 13:431-438.
91. Caldas A.M., Terreri M.T., Moises V.A., et al. The case for utilizing more strict quantitative Doppler echocardiographic criterions for diagnosis of subclinical rheumatic carditis. Cardiol Young 2007, 17:42-47.
92. Wilson N.J., Neutze J.M. Echocardiographic diagnosis of subclinical carditis in acute rheumatic fever [Editorial]. Int J Cardiol 1995, 50:1-6.
93. Veasy L.G. Myocardial dysfunction in active rheumatic carditis. J Am Coll Cardiol 1994, 24:581.
94. Veasy L.G. Echocardiographic diagnosis of rheumatic fever. Lancet 2001, 358:2000.
95. Elevli M., Çelebi A., Tombul T., Gökalp A.S. Cardiac involvement in Sydenham's chorea: Clinical and Doppler echocardiographic findings. Acta Paediatr 1999, 88:1074-1077.
96. Tubridy-Clark M., Carapetis J. Subclinical carditis in rheumatic fever: A systematic review. Int J Cardiol 2007, 119:54-58.
97. Davies C., Sahn D. Detection and significance of subclinical mitral regurgitation by colour Doppler techniques. Heart 2001, 85:369-370.
98. Brand A., Dollberg S., Keren A. The prevalence of valvular regurgitation in children with structurally normal hearts: A color Doppler echocardiographic study. Am Heart J 1992, 123:177-180.
99. Yoshida K., Yoshikawa J. Color Doppler evaluation of valvular regurgitation in normal subjects. Circulation 1988, 78:840-847.
100. Kostucki W., Vandenbossche J.L., Friart A., Englert M. Pulsed Doppler regurgitation flow patterns of normal valves. Am J Cardiol 1986, 58:309-313.
101. Choong C.Y., Abascal V.M., Weyman J., et al. Prevalence of valvular regurgitation by Doppler echocardiography in patients with structurally normal hearts by two-dimensional echocardiography. Am Heart J 1989, 117:636-641.
102. Figueroa F.E., Fernandez M.S., Valdés P., et al. Prospective comparison of clinical and echocardiographic diagnosis of rheumatic carditis: Long term follow up of patients with subclinical disease. Heart 2001, 85:407-410.
103. Abernethy M., Bass N., Sharpe N., et al. Doppler echocardiography and the early diagnosis of carditis in acute rheumatic fever. Aust N Z J Med 1994, 24:530-535.
104. Karaaslan S., Demiroren S., Oran B., et al. Criteria for judging the improvement in subclinical rheumatic valvitis. Cardiol Young 2003, 13:500-505.
105. Mota C.C.C. Doppler echocardiographic assessment of subclinical valvitis in the diagnosis of acute rheumatic fever. Cardiol Young 2001, 11:251-254.
106. Mota C.C.C. Rheumatic fever in the 21st century. Cardiol Young 2003, 13:491-494.
107. Veasy L.G. Time to take soundings in acute rheumatic fever. Lancet 2001, 357:1994-1995.
108. Narula J., Malhotra A., Yasuda T., et al. Usefulness of antimyosin antibody imaging for the detection of active rheumatic myocarditis. Am J Cardiol 1999, 84:946-950.
109. Narula J., Kaplan E.L. Echocardiographic diagnosis of rheumatic fever. Lancet 2001, 358:2000.
110. Ozkutlu S., Ayabakan C., Saraçlar M. Can subclinical valvitis detected by echocardiography be accepted as evidence of carditis in the diagnosis of acute rheumatic fever?. Cardiol Young 2001, 11:255-260.
111. Stollerman G.H. Current concepts of rheumatic fever. Internet J Cardiol 2003, (1):2.
112. Olgunturk R., Canter B., Tunaoglu F.S., Kula S. Review of 609 patients with rheumatic fever in terms of revised and updated Jones criteria. Int J Cardiol 2006, 112:91-98.
113. Hilàrio M.O., Andrade J.L., Gasparian A.B., et al. The value of echocardiography in the diagnosis and follow up of rheumatic carditis in children and adolescents: A 2 year prospective study. J Rheumatol 2000, 27:1082-1086.
114. Panamonta M., Chaikitpinyo A., Kaplan E.L., et al. The relationship of carditis to the initial attack of Sydenham's chorea. Int J Cardiol 2007, 94:241-248.
115. Marijon E., Phalla D., Celermajer D.S., et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007, 357:470-476.
116. Bittl J.A., PerloffJ.K. Chronic post-rheumatic fever arthropathy of Jaccoud. Am Heart J 1983, 105:515-517.
117. Beausang E., Barnett E.V., Goldstein S. Jaccoud's arthritis: A case report. Ann Rheum Dis 1967, 26:239-245.
118. Tutar E., Atalay S., Yilmaz E., et al. Poststreptococcal reactive arthritis in children: Is it really a different entity from rheumatic fever?. Rheumatol Int 2002, 22:80-83.
119. Mackie S.L., Keat A. Poststreptococcal reactive arthritis: What is it and how do we know?. Rheumatology 2004, 43:949-954.
120. Shulman S.T., Ayoub E.M. Poststreptococcal reactive arthritis. Curr Opin Rheumatol 2002, 14:562-565.
121. Stollerman G.H. Rheumatic fever. Lancet 1997, 349:935-942.
122. Cardoso F., Seppi K., Mair K.J., et al. Seminar on choreas. Neurology 2006, 5:589-602.
123. Nausieda P.A., Grossman B.J., Koller W.C., et al. Sydenham chorea: An update. Neurology 1980, 30:331-334.
124. Zomorrodi A., Ward E.R. Sydenham's chorea in western Pennsylvania. Pediatrics 2006, 117:e675-e679.
125. Bland E.F. Chorea as a manifestation of rheumatic fever: A long term perspective. Trans Am Climatolog Clin Assoc 1961, 73:209-213.
126. Cardoso F., Eduardo C., Silva A.P., Mota C.C. Chorea in fifty consecutive patients with rheumatic fever. Mov Disord 1997, 12:701-703.
127. Korn-Lubetzki I., Brand A., Steiner I. Recurrence of Sydenham chorea: Implications for pathogenesis. Arch Neurol 2004, 61:1261-1264.
128. Swedo S.E., Rapoport J.L., Cheslow D.L., et al. High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. Am J Psychiatry 1989, 146:246-249.
129. Maia D.P., Teixeira A.L., Cunningham M.C.Q., Cardoso F. Obsessive compulsive behavior, hyperactivity, and attention deficit disorder in Sydenham's chorea. Neurology 2005, 64:1799-1801.
130. Hounie A.C., Pauls D.L., Rosário-Campos M.C., et al. Obsessive-compulsive spectrum disorders and rheumatic fever: A family study. Biol Psychiatry 2007, 61:266-272.
131. Dale R.C., Heyman I., Sturtees R.A.H., et al. Dyskinesias and associated psychiatric disorders following streptococcal infections. Arch Dis Child 2004, 89:604-610.
132. Luo F., Leckman J.F., Katisovich L., et al. Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: Relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics 2004, 113:E578-E585.
133. Walker K.G., Lawrenson J., Wimshurst J.M. Neuropsychiatric movement disorders following streptococcal infection. Dev Med Child Neurol 2005, 47:771-775.
134. Mell L.K., Davis R.L., Owens D. Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder. Pediatrics 2005, 116:56-60.
135. Massel B.F., Fyler D.C., Roy S.B. The clinical picture of rheumatic fever: Diagnosis, immediate prognosis, course and therapeutic implications. Am J Cardiol 1958, 1:436-439.
136. Mota C.C.C., Meira Z.M.A., Graciano R.N., Silva M.C. Diagnostic aspects, carditis and other acute manifestations of streptococcal infection. Cardiol Young 1992, 2:222-228.
137. Ayoub E.M. Acute rheumatic fever. Moss and Adams' Heart Disease in Infants, Children, and Adolescents, Including the Fetus and Young Adult 2001, 1226-1241. Lippincott Williams & Wilkins, Philadelphia, Vol 2. 6th ed. H.D. Allen, E.B. Clack, H.P. Gutgesell, D.J. Driscoll (Eds.).
138. Saraiva L.R., Carneiro R.W., Wilcox G. Rheumatic pneumonia with carditis and arthritis in a three-year-old girl. Cardiol Young 1995, 5:197-198.
139. De La Fuente J., Nodar A., Sopeña B., Martinez C.A. Rheumatic pneumonia. Ann Rheum Dis 2001, 60:990-991.
140. Yamamoto L.G., Seto D.S.Y., Reddy D.V. Pneumonia associated with acute rheumatic fever. Clin Pediatr 1987, 26:198-200.
141. Dajani A., Taubert K., Ferrieri P., et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: A statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics 1995, 96(4 Pt 1):758-764.
142. Shet A., Kaplan E. Addressing the burden of group A streptococcal disease in India. Indian J Pediatr 2004, 71:41-48.
143. Roodpeyma S., Kamail Z., Zare R. Rheumatic fever: The relationship between clinical manifestations and laboratorial tests. J Paediatr Child Health 2005, 41:97-100.
144. Kula S., Olguntürk R., Özdemir O. Two unusual presentations of acute rheumatic fever. Cardiol Young 2005, 15:514-516.
145. Zalzstein E., Maor R., Zucker N., Katz A. Advanced atrioventricular conduction block in acute rheumatic fever. Cardiol Young 2003, 13:506-508.
146. Saraiva L.R., Santos C.L., Aguiar I.R. The prolongation of the QT interval in the acute rheumatic carditis: An enigma. Arq Bras Cardiol 2006, 87:e207-e212.
147. Polat T.B., Yalcin Y., Akdeniz C., et al. QT dispersion in acute rheumatic fever. Cardiol Young 2006, 16:141-146.
148. Zoghbi W.A., Enriquez-Sarano M., Foster E., et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003, 16:777-802.
149. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; Bonow RO, Carabello BA, Kanu C, et al: ACC/AHA 2006 Guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Developed in collaboration with the Society of Cardiovascular Anesthesiologists: Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-e231. Erratum in: Circulation 2007;115:e409.
150. Veasy L.G., Tani L.Y., Hill H.R. Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr 1994, 124:9-16.
151. Zhou L.-Y., Lu K. Inflammatory valvular prolapse produced by acute rheumatic carditis: Echocardiographic analysis of 66 cases of acute rheumatic carditis. Int J Cardiol 1997, 58:175-178.
152. Kamblock J., N'Guyen L., Pagis B., et al. Acute severe mitral regurgitation during first attacks of rheumatic fever: Clinical spectrum, mechanisms prognostic factors. J Heart Valve Dis 2005, 14:440-446.
153. Vijayalakshmi I.B., Mithravinda J., Deva A.N.P. The role of echocardiography in diagnosing carditis in the setting of acute rheumatic fever. Cardiol Young 2005, 15:583-588.
154. Kaymar C., Ozdemir N., Ozkan M. Differentiating clinical and echocardiographic characteristics of chordal rupture detected in patients with rheumatic mitral valve disease and floppy mitral valve: Impact of the infective endocarditis on chordal rupture. Eur J Echocardiogr 2005, 6:117-126.
155. Enriquez-Sarano M., Tajik A.J., SchaffH.V., et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation results and clinical implications. J Am Coll Cardiol 1994, 24:1536-1543.
156. Aziz K. An echocardiographic index for decompensation of the chronically volume-overloaded left ventricle in children. Cardiol Young 2005, 15:589-596.
157. Victor S. Dilemmas in the management of rheumatic heart disease. JAMA 1999, 97:265-270.
158. Albert D.A., Harel L., Karrison T. The treatment of rheumatic carditis: A review and meta-analysis. Medicine 1995, 74:1-12.
159. Cilliers A.M. Treating acute rheumatic fever. BMJ 2003, 327:631-632.
160. Cilliers A.M., Manyemba J., Saloojee H. Anti-inflammatory treatment for carditis in acute rheumatic fever. Cochrane Database Syst Rev 2003, (2). CD003176.
161. Voss L.M., Wilson N.J., Neutze J.M., et al. Intravenous gamma globulin in acute rheumatic fever: A randomized controlled trial. Circulation 2001, 103:401-406.
162. Feinstein A.R., Spagnuolo M., Gill F.A. Rebound phenomenon in acute rheumatic fever. 1. Incidence and significance. Yale J Biol Med 1961, 33:259-278.
163. Câmara E.J., Braga J.C., Alves-Silva L.S., et al. Comparison of an intravenous pulse of methylpredinosolone versus oral corticosteroid in severe acute rheumatic carditis: A randomized clinical trial. Cardiol Young 2002, 12:119-124.
164. Akcoral A., Oran B., Tavli V., et al. Effects of high-dose intravenous methylprednisolone in children with acute rheumatic carditis. Acta Paediatr Jpn 1996, 38:28-31.
165. Diab K.A., Timani M.A., Bitar F.F. Treatment of rheumatic carditis with intravenous gammaglobulin: Is there a beneficial treatment?. Cardiol Young 2001, 11:565-567.
166. Uziel Y., Hashkes P.J., Kassem E., et al. The use of naproxen in the treatment of children with rheumatic fever. J Pediatr 2000, 137:269-271.
167. Hashkes P.J., Tauber T., Somekh E., et al. Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: A randomized trial. J Pediatr 2003, 143:399-401.
168. Peña J., Mora E., Cardozo J., et al. Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham's chorea: Clinical follow-up of 18 patients. Arq Neuropsiquiatr 2002, 60:374-377.
169. Genel F., Arslanoglu S., Uran N., Saylan B. Sydenham's chorea: Clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens. Brain Dev 2002, 24:73-76.
170. Barash J., Margalith D., Matitiau A. Corticosteroid treatment in patients with Sydenham's chorea. Pediatr Neurol 2005, 32:205-207.
171. Cardoso F., Maia D., Cunningham M.C., Valença G. Treatment of Sydenham chorea with corticosteroids. Mov Disord 2003, 18:1374-1377.
172. Paz J.A., Silva C.A.A., Marques-Dias M.J. Randomized double-blind study with prednisone in Sydenham's chorea. Pediatr Neurol 2006, 34:264-269.
173. Garvey M.A., Zinder L.A., Leitman S.F., et al. Treatment of Sydenham's chorea with intravenous immunoglobulin, plasma exchange or prednisone. J Child Neurol 2005, 20:424-429.
174. Walker A.R., Tani L.Y., Thompson J.A., et al. Rheumatic chorea: Relationship to systemic manifestations and response to corticosteroids. J Pediatr 2007, 151:679-683.
175. Swedo S.E., Leonard H.L., Schapiro M.B., et al. Sydenham's chorea: Physical and psychological symptoms of St Vitus dance. Pediatrics 1993, 91:706-713.
176. Thatai D., Turi Z.G. Current guidelines for the treatment of patients with rheumatic fever. Drugs 1999, 57:545-555.
177. American Academy of Pediatrics Group A streptococcal infections. 2006 Report of the Committee on Infectious Diseases 2006, 610-620. American Academy of Pediatrics, Elk Grove Village, IL, Red Book. 27th ed. L.K. Pickering, C.J. Baker, S.S. Long, J.A. McMillan (Eds.).
178. Pochicheo M.E. A streptococcal tonsillopharyngitis cost-effective treatment. Ann Emerg Med 1995, 25:390-403.
179. Bisno A.L. Acute pharyngitis etiology and diagnosis. Pediatrics 1996, 97:949-954.
180. Einsenberg M.J. Rheumatic heart disease in developing world: Prevalence, prevention and control. Eur Heart J 1993, 14:122-128.
181. Stollerman G.H. Rheumatic fever in the 21st century. Clin Infect Dis 2001, 33:806-814.
182. Catanzaro F.J., Stetson C.A., Morris A.J., et al. The role of the streptococcus in the pathogenesis of rheumatic fever. Am J Med 1954, 17:749-756.
183. Robertson L.A., Volmick J.A., Mayosi B.M. Antibiotics for the primary prevention of acute rheumatic fever: A meta-analysis. BMC Cardiovasc Disord 2005, 5:2-11.
184. Markowitz M., Gerber M.A., Kaplan E.L. Treatment of streptococcal pharyngitis: Reports of penicillin's demise are premature. J Pediatr 1993, 123:679-685.
185. Gerber M.A. Tanz RR: New approaches to the treatment of group A streptococcal pharyngitis. Curr Opin Pediatr 2001, 13:51-55.
186. Alban B., Epstein J.A., Feinstein A.R., et al. Rheumatic fever in children and adolescents: A long term epidemiologic study of subsequent prophylaxis, streptococcal infections and clinical sequence. Ann Intern Med 1964, 60:1-29.
187. Ayoub E.M. Prophylaxis in patients with rheumatic fever: Every three or every four weeks. J Pediatr 1989, 115:89-91.
188. Manyemba J., Mayosi B.M. Intramuscular penicillin is more effective than oral penicillin in secondary prevention of rheumatic fever-a systemic review. S Afr Med J 2003, 93:212-218.
189. Currie B.J. Are the currently recommended doses of benzathine penicillin G adequate for secondary prophylaxis of rheumatic fever?. Pediatrics 1996, 97:989-991.
190. Meira Z.M.A., Mota C.C.C., Tonelli E., et al. Evaluation of secondary prophylactic schemes based on benzathine penicillin G for rheumatic fever in children. J Pediatr 1993, 123:156-157.
191. Lue H.C., Wu M.H., Wang J.K., et al. Long-term outcome of patients with rheumatic fever receiving benzathine penicillin G prophylaxis every three weeks versus every weeks. J Pediatr 1994, 125:812-816.
192. Lue H.C., Wu M.H., Wang J.K., et al. Three-versus four-week administration of benzathine penicillin G: Effects on incidence of streptococcal infections and recurrences of rheumatic fever. Pediatrics 1996, 97:984-988.
193. Kaplan E.L., Berrios X., Speth J., et al. Pharmacokinetics of benzathine penicillin G: Serum levels during the 28 days after intramuscular injection of 1,200,000 units. J Pediatr 1989, 115:146-150.
194. Ginsburg C.M., McCracken G.H., Zweighaft T.C. Serum penicillin concentrations after intramuscular administration of benzathine penicillin G in children. Pediatrics 1982, 69:452-454.
195. Kassem A.S., Zaher S.R., Abou Shleib H., et al. Rheumatic fever prophylaxis using benzathine penicillin G (BPG): Two-week versus four-week regimens: Comparison of two brands of BPG. Pediatrics 1996, 97:992-995.
196. Markowitz M., Lue H.C. Allergic reactions in rheumatic fever patients on long benzathine penicillin G: The role of skin testing for penicillin allergy. Pediatrics 1996, 97:981-983.
197. International Rheumatic Fever Study Group Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. Lancet 1991, 337:1308-1310.
198. Wilson W., Taubert K.A., Gewitz M., et al. American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Surgery and Anesthesia; Quality of Care and Outcomes Research Interdisciplinary Working Group: Prevention of infective endocarditis: Guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007, 116(9):1736-1754.
199. Steckelberg J.M., Wilson W.R. Risk factors for infective endocarditis. Infect Dis Clin North Am 1993, 7:9-19.
200. Ashrafian H., Bogle R.G. Antimicrobial prophylaxis for endocarditis: Emotion or science?. Heart 2007, 93:5-6.
201. Gould F.K., Elliott T.S.J., Foweraker J., et al. Guidelines for the prevention of endocarditis: Report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2006, 57:1035-1042.
202. Horstkotte D., Follath F., Gutschik E., et al. Grupo de Trabajo de Endocarditis Infecciosa de la Sociedad Europea de Cardiología: [Guidelines on prevention, diagnosis and treatment of infective endocarditis. Executive summary]. Rev Esp Cardiol 2004, 57:952-962.
203. Bessen D., Fischetti V.A. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect Immun 1988, 56:2666-2672.
204. Bessen D., Fischetti V.A. Synthetic peptide vaccine against mucosal colonization by group A streptococci. 1. Protection against a heterologous M serotype with shared C repeat region epitopes. J Immunol 1990, 145:1251-1256.
205. Guilherme L., Fae K.C., Higa F., et al. Towards a vaccine against rheumatic fever. Clin Dev Immunol 2006, 13:125-132.
206. KotloffK.L., Corretti M., Palmer K., et al. Safety and immunogenicity of a recombinant multivalent group A streptococcal vaccine in healthy adults: Phase 1 trial. JAMA 2004, 292:709-715.